Skip to main content
Equibles
BLLN logo

BLLN · BillionToOne, Inc. · Metrics

Track BLLN — free

Use BLLN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BLLN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$103.50 +2.47 (+2.44%) At close · Oct 20
Rebalance outlook locked
Market Cap
$4.86B
Shares
47.19M
Volume · Oct 20 398.77K Avg daily vol (3M) 666.88K

BLLN metrics

76 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$103.50
Market cap
$4.86B

Price action

20 metrics
Price change (1W)
+9.6%
Price change (30D)
-0.3%
Price change (3M)
-21.9%
Price change (6M)
+16.3%
Price change (YTD)
+26.5%
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
89.7%
Annualized volatility (3M)
98.8%
Beta
1.7
RSI (14D)
50.7
Price vs SMA 50
+2.3%
Price vs SMA 200
+8.1%
Avg volume (3M)
666,875
Relative volume
0.6
Average dollar volume
$70.90M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
47.19M

Valuation

12 metrics
P / E (TTM)
99.5
Trailing earnings · reciprocal yield 1.0%
PEG ratio
—
EV / revenue
11.1×
reciprocal yield 9.0%
EV / EBITDA
87.7×
reciprocal yield 1.1%
EV / EBIT
101.7×
reciprocal yield 1.0%
P / sales
12.2×
reciprocal yield 8.2%
P / book
9.1
reciprocal yield 11.0%
FCF yield
0.7%
TTM · current market cap
Buyback yield
—
P / FCF
146.5
reciprocal yield 0.7%
P / operating cash flow
107.2
reciprocal yield 0.9%
Earnings yield
0.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
71.3%
Operating margin
10.9%
Trailing 12 months
Net margin
9.5%
Gross profit (TTM)
$283.22M
Operating profit (TTM)
$43.30M
Net income (TTM)
$37.71M
Trailing 12 months
Diluted EPS (TTM)
$1.04
FCF margin
8.3%
Effective tax rate
0.5%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-21.43

Growth

11 metrics
Revenue growth YoY
+64.4%
Year over year
Net income growth YoY
—
Revenue (TTM)
$397.41M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+424.4%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
7.0%
Return on assets
5.2%
Debt / equity
0.2
Current ratio
11.7
EBITDA (TTM)
$50.23M
Free cash flow (TTM)
$33.17M
Quick ratio
11.3
Interest coverage
1,056.1
Net debt / EBITDA
-9.1
Return on invested capital
54.4%
Trailing 12 months
Net cash
$457.60M
Latest balance sheet
Cash & equivalents
$548.63M
Total assets
$729.70M
Total debt
$91.03M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$45.35M
Capital expenditures (TTM)
$12.18M
R&D (TTM)
$59.21M
SG&A (TTM)
$180.71M
Stock compensation (TTM)
$25.54M
R&D / revenue
14.9%
Stock compensation / revenue
6.4%

Ownership (13F)

9 metrics
13F filers
156
13F filer change QoQ
+65
Institutional ownership
32.7%
Conviction holders (share of 13F filers)
3.9%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+54.9%
Holder tenure
2.5
Price vs estimated holder cost
+27.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
3.8%

Short interest

3 metrics
Short interest
6.0%
Latest settlement · 3.9 days to cover
Days to cover
3.9d
Short-squeeze score
62 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$29.72M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 2070849 CUSIP 090168105 13F (30d) 17 filings 17 filers Visit website Investor relations